KIDNEY GRAFT-SURVIVAL IN CYCLOSPORINE-TREATED ALLOIMMUNIZED PATIENTS

被引：0
|
作者：
LINDHOLM, A [1 ]
MOLLER, E [1 ]
机构：
[1] KAROLINSKA INST,HUDDINGE HOSP,DEPT CLIN IMMUNOL,S-14186 HUDDINGE,SWEDEN
来源：
TRANSPLANTATION PROCEEDINGS | 1986年 / 18卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：23 / 26
页数：4
相关论文
共 50 条
  • [21] KIDNEY GRAFT-SURVIVAL IN PATIENTS TRANSFUSED PERIOPERATIVELY ONLY
    FASSBINDER, W
    FREI, U
    KUHNL, P
    SCHOPOW, K
    DATHE, G
    BLUT, 1982, 45 (01): : 71 - 72
  • [22] BELATACEPT-TREATED PATIENTS HAD SUPERIOR GRAFT SURVIVAL COMPARED WITH CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT
    Vincenti, F.
    Grinyo, J.
    Moal, M. -C.
    Rice, K.
    Rostaing, L.
    Steinberg, S.
    Meier-Kriesche, U.
    Polinsky, M.
    Larsen, C. P.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 51 - 51
  • [23] MULTIVARIATE-ANALYSIS OF RISK-FACTORS LEADING TO KIDNEY GRAFT LOSS IN CYCLOSPORINE-TREATED PATIENTS
    SINCLAIR, NRS
    STILLER, CR
    JEFFERY, JR
    KEOWN, PA
    TRANSPLANTATION PROCEEDINGS, 1988, 20 (01) : 350 - 352
  • [24] Belatacept-treated patients had superior graft survival compared with cyclosporine-treated patients: final results from BENEFIT
    Vincenti, Flavio
    Bray, Robert
    Gebel, Howard
    Grinyo, Josep
    Moal, Marie-Christine
    Rice, Kim
    Rostaing, Lionel
    Steinberg, Steven
    Meier-Kriesche, Ulf
    Polinsky, Martin
    Townsend, Robert
    Larsen, Christian P.
    SWISS MEDICAL WEEKLY, 2015, 145 : 10S - 11S
  • [25] SIGNIFICANCE OF DELAYED GRAFT FUNCTION IN CYCLOSPORINE-TREATED RECIPIENTS OF CADAVER KIDNEY-TRANSPLANTS
    BARRY, JM
    SHIVELY, N
    HUBERT, B
    HEFTY, T
    NORMAN, DJ
    BENNETT, WM
    TRANSPLANTATION, 1988, 45 (02) : 346 - 348
  • [26] CENTER EFFECT AND KIDNEY GRAFT-SURVIVAL
    CICCIARELLI, J
    MICKEY, MR
    TERASAKI, PI
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (06) : 2803 - 2807
  • [27] DIALYSIS METHOD AND KIDNEY GRAFT-SURVIVAL
    KYLLONEN, L
    HELANTERA, A
    SALMELA, K
    AHONEN, J
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (01) : 354 - 354
  • [28] THE INFLUENCE OF DONOR-SPECIFIC MLC REACTIVITY ON CADAVER KIDNEY GRAFT-SURVIVAL IN PATIENTS ON CONVENTIONAL OR CYCLOSPORINE TREATMENT
    LANGHOFF, E
    JAKOBSEN, BK
    LADEFOGED, J
    LOKKEGAARD, H
    PLATZ, P
    RYDER, LP
    THAYSEN, JH
    SVEJGAARD, A
    TRANSPLANTATION PROCEEDINGS, 1986, 18 (01) : 16 - 17
  • [29] EVIDENCE THAT ZERO ANTIGEN-MATCHED CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS HAVE GRAFT-SURVIVAL EQUAL TO THAT OF MATCHED RECIPIENTS - REEVALUATION OF POINTS
    GREENSTEIN, SM
    SCHECHNER, RS
    LOUIS, P
    SENITZER, D
    MATAS, A
    VEITH, FJ
    TELLIS, VA
    TRANSPLANTATION, 1990, 49 (02) : 332 - 336
  • [30] IMMUNOLOGICAL MONITORING IN CYCLOSPORINE-TREATED PATIENTS
    MCKENNA, RM
    SCHROEDER, TJ
    CLINICAL BIOCHEMISTRY, 1991, 24 (01) : 75 - 80
12345